Product Information
CHILDREN IBUPROFEN 100 MG/5 ML is a generic product labeled by BluePoint Laboratories, priced at $0.0297 per ML under NDC 68001052192. Its NADAC has been published 202 times since Oct 12, 2022.
FDA first approved this application on Apr 17, 2018.
The Low Outlier badge above means this manufacturer's average price in the Ibuprofen market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/5mL
Manufacturer
BluePoint LaboratoriesNDC
68001052192
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA209179FDA Approved
4/17/2018
On Market Since
9/12/2022
Pharmacological Classes
Price Statistics
The NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has been published 202 times since Oct 12, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0297 per ML |
|---|---|
| All-time high | $0.0329 (Jul 12, 2023) |
| All-time low | $0.0274 (Aug 21, 2024) |
| 52-week high | $0.0304 |
| 52-week low | $0.0290 |
| Median price | $0.0295 |
| Average price | $0.0297 |
| Largest weekly change | +14.0% (Apr 19, 2023) |
| Weeks tracked | 202 |
| Tracking since | Oct 12, 2022 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHILDREN IBUPROFEN 100 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for CHILDREN IBUPROFEN 100 MG/5 ML, manufactured by BluePoint Laboratories, is $0.0297 per ML (NDC 68001052192), effective Aug 19, 2026.
How has the price of CHILDREN IBUPROFEN 100 MG/5 ML changed over time?
Over the history we have for it, the NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has held within roughly two percent of its current level. It has been tracked across 202 weekly CMS publications since Oct 12, 2022.
What are the highest and lowest recorded NADAC prices for CHILDREN IBUPROFEN 100 MG/5 ML?
Since Oct 12, 2022, the NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has ranged from a low of $0.0274 (Aug 21, 2024) to a high of $0.0329 (Jul 12, 2023), with a median of $0.0295 per ML.
Are there cheaper alternatives to CHILDREN IBUPROFEN 100 MG/5 ML?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 100 MG/5 ML SUSP, is $0.0239 per ML — about 19% below CHILDREN IBUPROFEN 100 MG/5 ML.
Who manufactures CHILDREN IBUPROFEN 100 MG/5 ML?
CHILDREN IBUPROFEN 100 MG/5 ML (NDC 68001052192) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.